Profile
Björn Löwenadler is currently the Director at Adjuvare AB and the Chief Business Officer at Toleranzia AB. He previously held positions as an Independent Director at Alzinova AB, Director at Agrisera AB, Head of Discovery Sciences at AstraZeneca PLC, Head of Molecular Biology at Pharmacia Corp., Chief Scientific Officer at Arexis AB, and Head of Discovery Research at BioVitrum.
Dr. Löwenadler obtained a doctorate degree from Karolinska Institutet.
Björn Löwenadler active positions
| Companies | Position | Start |
|---|---|---|
Adjuvare AB
Adjuvare AB Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Director/Board Member | - |
Former positions of Björn Löwenadler
| Companies | Position | End |
|---|---|---|
BioVitrum
BioVitrum Medical SpecialtiesHealth Technology Manufactures diagnostic and laboratory equipment | Corporate Officer/Principal | - |
Agrisera AB
Agrisera AB Miscellaneous Commercial ServicesCommercial Services Produces polyclonal and monoclonal antibody | Director/Board Member | - |
| TOLERANZIA AB | Corporate Officer/Principal | - |
| ALZINOVA AB | Director/Board Member | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Training of Björn Löwenadler
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 9 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Alzinova AB
Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
BioVitrum
BioVitrum Medical SpecialtiesHealth Technology Manufactures diagnostic and laboratory equipment | Health Technology |
Toleranzia AB
Toleranzia AB BiotechnologyHealth Technology Operates as a biotechnology company that develops drugs for the treatment of autoimmune orphan diseases | Health Technology |
Agrisera AB
Agrisera AB Miscellaneous Commercial ServicesCommercial Services Produces polyclonal and monoclonal antibody | Commercial Services |
Adjuvare AB
Adjuvare AB Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
- Stock Market
- Insiders
- Björn Löwenadler
















